Make a difference

Based upon the initial concept of transferring academic knowledge into valuable industrial applications, NovAliX is a private company owned by its executive management, scientific founders and employees and located near Strasbourg (France).

After two decades of delivering excellent outcomes in chemistry and biophysics for our clients, NovAliX has become a trusted provider of expert services to partners ranging from virtual companies to global players.

NovAliX can provide a valuable extension to the in-house capabilities of our partners, from biopharmaceutical companies to venture capital firms, by forging creative alliances tailored to individual needs. NovAliX has pioneered the concept and practice of insourcing in Europe, has engaged in risk-sharing collaborations with biotechnology investors, and has also formed an alliance with a major pharmaceutical company to co-develop DNA-encoded library technology.

2002
Academic spinoffs Novalyst Discovery and AliX
2008
Combining chemistry and biophysics Merger of Novalyst Discovery and AliX to form NovAliX
2010
Insourcing Pioneering colocated research collaborations
2016
Cryo-EM In-house joint facility with Thermo Fisher Scientific
2020
DNA-encoded libraries Technology alliance with major pharmaceutical company
2022
Drug Discovery expansion Guy Ourisson Research Campus

Management

We have cohesive management team, with a blend of scientific, entrepreneurial and operational expertise. The team is passionate about the interplay between industry and science and is convinced that CROs have a growing role in the discovery of new medicines.

Stephan Jenn

Stephan Jenn

President

Stephan met inspirational people from the life science and venture capital industries while attending the Wharton Business School and co-founded NovAliX shortly after his return to France in 2002.
Denis Zeyer

Denis Zeyer

CEO

Earned his PhD from Strasbourg University and was trained as a protein crystallographer at the Institute of Genetics and Molecular and Cellular Biology by NovAliX co-founders D. Moras and J.P. Renaud.
Christophe Dubost

Christophe Dubost

Chief Financial Officer

Christophe graduated from ESSEC Business School with a venture and entrepreneurial background before joining NovAliX in 2010.
Julien Marin

Julien Marin

VP, Director Research Services

Julien earned his PhD in chemistry from Strasbourg University and a Master’s degree from HEC Paris. He completed his post-doctoral training with S. Hanessian in Montreal and joined NovAliX in 2006.
Florence Donadini

Florence Donadini

VP, Human Resources Director

Florence is an all-round specialist in human resources. She trained at EM Business School in Strasbourg. Before joining, Florence was HR Director for a well-known manufacturer of sport equipment.
Jérôme Guillemont

Jérôme Guillemont

VP, Head of Drug Discovery Business Unit

Jérôme brings a wealth of experience in drug discovery with more than thirty years in pharmaceutical companies, working in numerous drug candidates. Jérôme's work has delivered two  and has been widely recognized by the scientific community.

Xavier Espanel

Xavier Espanel

VP, Director Co-located Research

PhD in molecular and cellular biology at ENS Lyon. Followed a post-doc training at Mount Sinaï School of Medicine and Merck Sereno. Experienced in pharma and biotech companies, joined NovAliX in 2017
Marco Pintore

Marco Pintore

VP, Director of Business Development & Marketing

Marco has exercised management responsibilities in the consulting business, as an entrepreneur or transition manager, in the field of life sciences. He successfully managed BioValley France, cluster dedicated to the therapeutic innovations and health, before joining NovAliX.

Our partners

Reach Separations
Alysophil
ThermoFisher